Related content

Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma

By                

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1017-1022

Spandidos Publications

Access to resources Recommend Favorite

A case of diaphragmatic clear cell carcinoma in a patient with a medical history of ovarian endometriosis

By Fujiu Koichi   Miyamoto Hideaki   Hashimoto Satoshi   Suzuki Nobuyasu   Takano Yoshinao   Teranishi Yasushi   Sakuma Hideo   Suzuki Hiroyuki  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 489-492

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)

By                        

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 487-493

Spandidos Publications

Access to resources Recommend Favorite

Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma

By                    

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 2122-2130

Spandidos Publications

Access to resources Recommend Favorite

Bilateral Ovarian Metastases from Renal Clear Cell Carcinoma

By Vara Alejandro   Madrigal Beatriz   Veiga Manuel   Diaz Ana   García Juan   Calvo Juan  

Acta Oncologica, Vol. 37, Iss. 4, 1998-10 ,pp. : 379-380

Informa Healthcare

Access to resources Recommend Favorite